Aerie Pharmaceuticals
Why Robinhood?
You can watch AERI and buy or sell other stocks, ETFs, and their options commission-free!About AERI
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105.
AERI Key Statistics
Stock Snapshot
As of today, Aerie Pharmaceuticals(AERI) shares are valued at $15.25. The company's market cap stands at 753.62M, with a P/E ratio of -19.89.
On 2026-04-03, Aerie Pharmaceuticals(AERI) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Aerie Pharmaceuticals(AERI) stock has reached 0, versus its average volume of 515.67K.
The stock's 52-week range extends from a low of $4.81 to a high of $15.37.
The stock's 52-week range extends from a low of $4.81 to a high of $15.37.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.